Back to Gene
HINT1 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

HINT1 gene

The HINT1 gene encodes a protein involved in nervous system function and cell regulation, with mutations linked to a specific form of axonal neuropathy.

Normal Function

The HINT1 gene provides instructions for making a protein called histidine triad nucleotide-binding protein 1 (HINT1). While the exact function is not fully clear, laboratory studies show that HINT1 has the ability to bind to nucleotides and break them down through a process called hydrolysis.

The HINT1 protein is involved in the nervous system. In nerve cells (neurons), HINT1 binds to signaling proteins called receptors that relay signals affecting nervous system function. HINT1 appears to stabilize the interaction of different receptors and regulate the effects of their signaling.

Additionally, HINT1 is involved in programmed cell death (apoptosis) and acts as a tumor suppressor by blocking the activity of certain genes, preventing cells from growing and dividing too rapidly or in an uncontrolled way.

Health Conditions Related to Genetic Changes

Autosomal recessive axonal neuropathy with neuromyotonia

At least nine mutations in the HINT1 gene have been found to cause autosomal recessive axonal neuropathy with neuromyotonia. This neurological condition affects the peripheral nerves, which connect the brain and spinal cord to muscles and sensory cells.

Common signs and symptoms include:

  • Muscle weakness in the feet, legs, and hands
  • Delayed relaxation of muscles after tensing (neuromyotonia)
  • Mildly impaired sensations in some individuals

The HINT1 gene mutations that cause this condition change single amino acids in the HINT1 protein, reducing or eliminating the protein's ability to perform the hydrolysis reaction. Sometimes the altered protein is broken down prematurely. It is not yet clear how the loss of functional HINT1 protein leads to the specific signs and symptoms of this condition.

Charcot-Marie-Tooth disease

Mutations in the HINT1 gene have also been associated with Charcot-Marie-Tooth disease.

Frequently Asked Questions

Diagnosis usually involves a neurological examination, nerve conduction studies, and electromyography (EMG) to assess nerve and muscle function. Genetic testing for mutations in the HINT1 gene is crucial to confirm the diagnosis, especially given its autosomal recessive inheritance pattern.
Management is primarily supportive and aims to alleviate symptoms. Physical therapy and occupational therapy can help maintain muscle strength, improve mobility, and adapt to daily challenges. Medications may be prescribed to help manage neuromyotonia (muscle stiffness/spasms) and improve muscle relaxation.
Yes, it is generally considered a progressive condition, meaning symptoms may worsen over time, though the rate of progression can vary. While there is no cure, ongoing supportive care, therapy, and symptom management can help maintain quality of life and address evolving challenges. Regular follow-ups with a neurologist are important.
Early signs often include muscle weakness, particularly in the feet, legs, and hands, which can lead to difficulty walking or performing fine motor tasks. Neuromyotonia, or delayed muscle relaxation after tensing, is another key symptom and might be noticed as stiffness or cramping. Consult a doctor if these symptoms develop, especially if they are progressive.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA